Dr. Sparks is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-5325Fax+1 617-732-5766- Is this information wrong?
Education & Training
- Harvard Medical SchoolMMSc, Patient-oriented research, 2012 - 2014
- Brigham and Women's HospitalFellowship, Rheumatology, 2011 - 2014
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2007 - 2010
- University of Arkansas For Medical Sciences College of MedicineClass of 2007
- University of ArkansasBS, Physics, Summa cum laude, 1999 - 2003
Certifications & Licensure
- MA State Medical License 2011 - 2024
- MO State Medical License 2009 - 2014
- American Board of Internal Medicine Rheumatology
Clinical Trials
- Cardiovascular Inflammation Reduction Trial Start of enrollment: 2013 Apr 01
- Personalized Risk Estimator for Rheumatoid Arthritis Family Study Start of enrollment: 2014 Jan 01
Publications & Presentations
PubMed
- Pre-existing Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events, and Can...Jeffrey A Sparks> ;Rheumatic Diseases Clinics of North America. 2024 May 1
- The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events.Alexandra Ladouceur, Aiarpi Ezdoglian, Marie Hudson, Shahin Jamal, Alison Clifford, Janet Roberts, Carrie Ye, Jeffrey A Sparks> ;Rheumatic Diseases Clinics of North America. 2024 May 1
- Immune Checkpoint Inhibitor-induced Inflammatory Arthritis: Current Approaches to Management.Samuel Bitoun, Namrata Singh, Anupama Shahane, Jeffrey A Sparks, Laura C Cappelli> ;Rheumatic Diseases Clinics of North America. 2024 May 1
- Join now to see all
Press Mentions
- Normal CRP During RA Flares: An ‘Underappreciated, Persistent Phenotype’May 5th, 2023
- Long-COVID Rate May Be Higher with Rheumatic DiseasesMay 2nd, 2023
- Researchers Seek to Understand Post-COVID Autoimmune Disease RiskMay 1st, 2023
- Join now to see all
Grant Support
- Scientist Development AwardRheumatology Research Foundation2014–Present
Professional Memberships
- Member
- Fellow
Hospital Affiliations
- Dana-Farber Cancer InstituteBoston, Massachusetts
- Brigham and Women's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: